Related Experiment Video
Updated: Jul 19, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Pediatric HIV/AIDS and the skin: an update
1Division of Dermatology, Red Cross Children's Hospital and the University of Cape Town, Klipfontein Road, Rondebosch, Cape Town, 7700, South Africa. gavgott@ich.uct.ac.za
Insights
Pediatric HIV/AIDS in sub-Saharan Africa affects millions, with skin conditions being common. This review covers epidemiology, skin disease as an immune indicator, immune reconstitution inflammatory syndrome, and antiretroviral impacts.
Area of Science:
- Pediatric infectious diseases
- Dermatology
- Immunology
Background:
- Sub-Saharan Africa had 2.1 million children under 15 living with HIV in 2005.
- Skin diseases are a common co-morbidity in pediatric HIV/AIDS, mirroring adult trends.
Purpose of the Study:
- To provide an updated overview of pediatric HIV/AIDS and its dermatological manifestations.
- To examine skin conditions as indicators of immune status in children with HIV.
- To discuss immune reconstitution inflammatory syndrome (IRIS) and the effects of antiretroviral therapy (ART) on skin disease.
Main Methods:
- Literature review and synthesis of current data on pediatric HIV/AIDS.
- Analysis of epidemiological trends in sub-Saharan Africa.
- Review of the relationship between skin manifestations and immune status, IRIS, and ART.
Main Results:
- Skin diseases are highly prevalent in children with HIV/AIDS.
- Cutaneous manifestations can serve as valuable indicators of a child's immune status.
- IRIS and ART significantly influence the spectrum and management of skin conditions.
Conclusions:
- Understanding the epidemiology and dermatological aspects of pediatric HIV/AIDS is crucial for effective management.
- Skin health monitoring is essential for assessing immune function and treatment response in HIV-infected children.
- Further research is needed to optimize the management of skin diseases in the context of evolving HIV/AIDS treatment.
Abstract:
In 2005 there were 2.1 million children under the age of 15 years living with HIV in sub-Saharan Africa. As in the adult pandemic, attendant skin disease is prevalent in children. This article provides an update of pediatric HIV/AIDS and its cutaneous manifestations from four main aspects: epidemiology, skin disease as an indicator of immune status, immune reconstitution inflammatory syndrome, and the impact of antiretroviral agents on skin disease.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

